C4B and Schnyder corneal dystrophy: While further studies are needed, especially to better understand the prognostic value of rare mutations, particularly in the setting of conditioning, transplant, or other treatment regimens, our findings are likely to inform clinical decisions and suggest that CH surveillance as part of routine clinical care for SCD patients is no more indicated at the current time than it is in the general population.